
1. cmaj. 2017 nov 27;189(47):e1448-e1458. doi: 10.1503/cmaj.170494.

canadian guideline hiv pre-exposure prophylaxis nonoccupational
postexposure prophylaxis.

tan dhs(1), hull mw(2), yoong d(2), tremblay c(2), o'byrne p(2), thomas r(2),
kille j(2), baril jg(2), cox j(2), giguere p(2), harris m(2), hughes c(2),
macpherson p(2), o'donnell s(2), reimer j(2), singh a(2), barrett l(2), bogoch
i(2), jollimore j(2), lambert g(2), lebouche b(2), metz g(2), rogers t(2),
shafran s(2); biomedical hiv prevention working group cihr canadian hiv
trials network.

author information: 
(1)division infectious diseases (tan), st. michael's hospital, toronto, ont.; 
bc centre excellence hiv/aids (hull, harris), vancouver, bc; department of
pharmacy (yoong), st. michael's hospital, toronto, ont.; centre de recherche du
centre hospitalier de l'université de montréal (tremblay), montréal, que.; school
of nursing (o'byrne), university ottawa, ottawa, ont.; clinique l'actuel
(thomas), montréal, que.; canadian association nurses hiv/aids care
(kille), vancouver, bc; clinique du quartier latin (baril), montréal, que.;
direction régionale de santé publique (cox), centre intégré universitaire de
santé et de services sociaux du centre-sud-de-l'île-de-montréal, montréal, que.; 
department pharmacy (giguere), ottawa hospital, ottawa, ont.; faculty of
pharmacy & pharmaceutical sciences (hughes), university alberta, edmonton,
alta.; division infectious diseases (macpherson), ottawa hospital, ottawa,
ont.; department emergency medicine (o'donnell), st. paul's hospital,
vancouver, bc; winnipeg regional health authority (reimer), winnipeg, man.;
division infectious diseases, department medicine (singh, shafran),
university alberta, edmonton, alta.; dalhousie university (barrett), halifax, 
ns; divisions internal medicine infectious diseases (bogoch), toronto
general hospital, toronto, ont.; health initiative men (jollimore),
vancouver, bc; institut national de santé publique du québec (lambert), montréal,
que.; research institute mcgill university health centre (lebouche),
montréal, que.; catie (canadian aids treatment information exchange) (rogers),
toronto, ont. darrell.tan@gmail.com.
(2)division infectious diseases (tan), st. michael's hospital, toronto, ont.; 
bc centre excellence hiv/aids (hull, harris), vancouver, bc; department of
pharmacy (yoong), st. michael's hospital, toronto, ont.; centre de recherche du
centre hospitalier de l'université de montréal (tremblay), montréal, que.; school
of nursing (o'byrne), university ottawa, ottawa, ont.; clinique l'actuel
(thomas), montréal, que.; canadian association nurses hiv/aids care
(kille), vancouver, bc; clinique du quartier latin (baril), montréal, que.;
direction régionale de santé publique (cox), centre intégré universitaire de
santé et de services sociaux du centre-sud-de-l'île-de-montréal, montréal, que.; 
department pharmacy (giguere), ottawa hospital, ottawa, ont.; faculty of
pharmacy & pharmaceutical sciences (hughes), university alberta, edmonton,
alta.; division infectious diseases (macpherson), ottawa hospital, ottawa,
ont.; department emergency medicine (o'donnell), st. paul's hospital,
vancouver, bc; winnipeg regional health authority (reimer), winnipeg, man.;
division infectious diseases, department medicine (singh, shafran),
university alberta, edmonton, alta.; dalhousie university (barrett), halifax, 
ns; divisions internal medicine infectious diseases (bogoch), toronto
general hospital, toronto, ont.; health initiative men (jollimore),
vancouver, bc; institut national de santé publique du québec (lambert), montréal,
que.; research institute mcgill university health centre (lebouche),
montréal, que.; catie (canadian aids treatment information exchange) (rogers),
toronto, ont.

erratum in
    cmaj. 2018 jun 25;190(25):e782.

doi: 10.1503/cmaj.170494 
pmcid: pmc5703677
pmid: 29180384  [indexed medline]

conflict interest statement: competing interests: darrell tan reports grants
from canadian institutes health research ontario hiv treatment
network, conduct study, personal fees merck gsk
and grants personal fees gilead viiv healthcare, outside the
submitted work. mark hull reports receiving honoraria advisory board
representation speaking engagements regarding hiv hepatitis c virus
from bms, gilead, merck viiv healthcare, paid institution. deborah
yoong reports personal fees merck gilead science, outside submitted 
work. cécile tremblay reports grants personal fees gilead, merck, viiv
healthcare, canadian institutes health research fonds de recherche
santé québec, conduct study outside submitted
work. réjean thomas reports personal fees gilead, outside submitted
work. jean-guy baril reports grants gilead, merck glaxo, personal
fees gilead, merck viiv healthcare, outside submitted work. joseph
cox reports grants personal fees viiv healthcare, grants merck 
and gilead, outside submitted work. pierre giguere reports grants and
personal fees gilead sciences, viiv healthcare merck outside the
submitted work. marianne harris reports grants personal fees gilead
sciences canada personal fees merck canada viiv healthcare, outside 
the submitted work. christine hughes reports grants personal fees viiv
healthcare, personal fees merck canada gilead sciences canada,
outside submitted work. stephen shafran reports grants abbvie, gilead
and janssen; grants personal fees merck bms; personal fees 
pfizer, outside submitted work. competing interests declared.

